WO2005025669A3 - Constant current electroporation device and methods of use - Google Patents

Constant current electroporation device and methods of use Download PDF

Info

Publication number
WO2005025669A3
WO2005025669A3 PCT/US2004/028998 US2004028998W WO2005025669A3 WO 2005025669 A3 WO2005025669 A3 WO 2005025669A3 US 2004028998 W US2004028998 W US 2004028998W WO 2005025669 A3 WO2005025669 A3 WO 2005025669A3
Authority
WO
WIPO (PCT)
Prior art keywords
electroporation device
methods
ekd
constant current
electrodes
Prior art date
Application number
PCT/US2004/028998
Other languages
French (fr)
Other versions
WO2005025669A2 (en
Inventor
Louis C Smith
Ruxandra Draghia-Akli
Amir S Khan
Robert H Carpenter
Jeff Darnell
Original Assignee
Advisys Inc
Louis C Smith
Ruxandra Draghia-Akli
Amir S Khan
Robert H Carpenter
Jeff Darnell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advisys Inc, Louis C Smith, Ruxandra Draghia-Akli, Amir S Khan, Robert H Carpenter, Jeff Darnell filed Critical Advisys Inc
Priority to ES04788598.3T priority Critical patent/ES2668384T3/en
Priority to EP04788598.3A priority patent/EP1673140B1/en
Priority to PL04788598T priority patent/PL1673140T3/en
Priority to CA2578847A priority patent/CA2578847C/en
Publication of WO2005025669A2 publication Critical patent/WO2005025669A2/en
Publication of WO2005025669A3 publication Critical patent/WO2005025669A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0472—Structure-related aspects
    • A61N1/0476—Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)

Abstract

An electroporation device which may be used to effectively facilitate the introduction of a macromolecule into cells of a selected tissue in a body or plant. The electroporation device comprises an electro-kinetic device (' EKD') whose operation is specified by software or firmware. The EKD produces a series of programmable constant-current pulse patterns between electrodes in an array based on user control and input of the pulse parameters and allows the storage and acquisition of current waveform data. The electroporation device also comprises a replaceable electrode disk having an array of needle electrodes, a central injection channel for an injection needle, and a removable guide disk.
PCT/US2004/028998 2003-09-08 2004-09-03 Constant current electroporation device and methods of use WO2005025669A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES04788598.3T ES2668384T3 (en) 2003-09-08 2004-09-03 Electroporation device with constant current
EP04788598.3A EP1673140B1 (en) 2003-09-08 2004-09-03 Constant current electroporation device
PL04788598T PL1673140T3 (en) 2003-09-08 2004-09-03 Constant current electroporation device
CA2578847A CA2578847C (en) 2003-09-08 2004-09-03 Constant current electroporation device and methods of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/657,725 US8209006B2 (en) 2002-03-07 2003-09-08 Constant current electroporation device and methods of use
US10/657,725 2003-09-08

Publications (2)

Publication Number Publication Date
WO2005025669A2 WO2005025669A2 (en) 2005-03-24
WO2005025669A3 true WO2005025669A3 (en) 2005-08-04

Family

ID=34312678

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/028998 WO2005025669A2 (en) 2003-09-08 2004-09-03 Constant current electroporation device and methods of use

Country Status (9)

Country Link
US (1) US8209006B2 (en)
EP (1) EP1673140B1 (en)
AR (1) AR045603A1 (en)
CA (1) CA2578847C (en)
ES (1) ES2668384T3 (en)
HU (1) HUE038018T2 (en)
PL (1) PL1673140T3 (en)
TW (1) TWI246930B (en)
WO (1) WO2005025669A2 (en)

Families Citing this family (154)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080269153A1 (en) * 2002-05-28 2008-10-30 Ruxandra Draghia-Akli Increased stability of a dna formulation by including poly-l-glutamate
US7846720B2 (en) * 2005-01-26 2010-12-07 Vgx Pharmaceuticals, Inc. Optimized high yield synthetic plasmids
EP2266656B1 (en) * 2005-04-18 2020-10-28 INSERM (Institut National de la Santé et de la Recherche Médicale) Devices for delivering a biologically active agent to the ocular sphere of a subject
FR2893256B1 (en) * 2005-11-14 2008-08-15 Yves Scherman GENERATOR OF ELECTRIC PULSES UNIPOLAR.
AU2007215263B2 (en) * 2006-02-11 2011-07-07 Genetronics, Inc. Device and method for single-needle in vivo electroporation
DE102006009157B4 (en) * 2006-02-24 2015-08-20 Eisenmann Ag Method for digesting biological material and device for its implementation
KR101529448B1 (en) * 2006-03-03 2015-06-18 온코섹 메디컬 인코포레이티드 Device for treating microscopic residual tumors remaining in tissues following surgical resection
DK2032057T3 (en) * 2006-06-12 2010-02-08 Region Hovedstaden V Herlev Ho Electrode insertion device
US7576549B2 (en) * 2006-09-21 2009-08-18 Bio-Rad Laboratories, Inc. Methods for measuring sample resistance in electroporation
KR101421760B1 (en) * 2006-10-17 2014-07-22 브이지엑스 파머시우티컬즈, 인크. Electroporation devices and methods of using same for electroporation of cells in mammals
EP2799547B1 (en) 2006-11-08 2016-12-21 Veritas Bio, LLC In Vivo Delivery of RNA to a Target Cell
US20100247437A1 (en) * 2007-10-01 2010-09-30 Vgx Pharmaceuticals, Llc Materials and methods for the delivery of biomolecules to cells of an organ
US9592285B2 (en) 2007-11-12 2017-03-14 The Trustees Of The University Of Pennsylvania Vaccines against multiple subtypes of influenza virus
EP2209490A4 (en) * 2007-11-14 2013-01-09 VGX Pharmaceuticals LLC Antibody production elicited by a dna vaccine delivered by electroporation
US8835620B2 (en) 2008-01-11 2014-09-16 Vgx Pharmaceuticals, Llc Vaccines against multiple subtypes of dengue virus
AU2009231598B2 (en) 2008-04-04 2015-03-12 The Trustees Of The University Of Pennsylvania Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same
JP5744719B2 (en) * 2008-04-04 2015-07-08 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Chikungunya virus protein consensus sequence, nucleic acid molecule encoding the same, and compositions and methods using the same
KR101708277B1 (en) 2008-05-28 2017-02-20 이노비오 파마수티컬즈, 인크. Smallpox dna vaccine and the antigens therein that elicit an immune response
US8921536B2 (en) 2008-10-29 2014-12-30 The Trustees Of The University Of Pennsylvania HCV vaccines and methods for using the same
JP5753090B2 (en) 2008-10-29 2015-07-22 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Improved HCV vaccine and method of use thereof
WO2010057159A2 (en) 2008-11-17 2010-05-20 Vgx Pharmaceuticals, Llc Antigens that elicit immune response against flavivirus and methods of using same
TWI423790B (en) * 2008-11-18 2014-01-21 Univ Nat Chiao Tung An adjustable implant electrode system and the implant electrode thereof
CA2653478A1 (en) 2009-01-23 2010-07-23 Gregg Martin Automated wash system for industrial vehicles
US9050287B2 (en) 2009-01-23 2015-06-09 The Trustees Of The University Of Pennsylvania Vaccines for human papilloma virus and methods for using the same
KR101851699B1 (en) 2009-11-02 2018-04-24 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
US8298820B2 (en) 2010-01-26 2012-10-30 The Trustees Of The University Of Pennsylvania Influenza nucleic acid molecules and vaccines made therefrom
WO2011097640A1 (en) 2010-02-08 2011-08-11 The Trustees Of The University Of Pennsylvania Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
MX355501B (en) 2010-09-27 2018-04-20 Inovio Pharmaceuticals Inc Star Consensus antigen constructs and vaccines made therefrom, and methods of using same to treat malaria.
CA2817709C (en) 2010-11-12 2021-06-01 The Trustees Of The University Of Pennsylvania Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same
MX347856B (en) 2011-01-28 2017-05-16 Massachusetts Gen Hospital Method and apparatus for skin resurfacing.
WO2012103483A2 (en) 2011-01-28 2012-08-02 The General Hospital Corporation Apparatus and method for tissue biopsy
PT2667801T (en) 2011-01-28 2019-03-04 Massachusetts Gen Hospital Method and apparatus for discontinuous dermabrasion
JP6099573B2 (en) 2011-01-31 2017-03-22 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Nucleic acid molecules encoding novel herpes antigens, vaccines containing them and methods of use thereof
US9238679B2 (en) 2011-02-11 2016-01-19 The Trustees Of The University Of Pennslyvania Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
EA032364B1 (en) 2011-02-11 2019-05-31 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same
ITTO20110374A1 (en) * 2011-04-29 2012-10-30 Igea S P A METHOD OF CONTROL OF AN ELECTRO-PORTION DEVICE
EP3662935A1 (en) 2011-07-11 2020-06-10 Inovio Pharmaceuticals, Inc. Cross-protective arenavirus vaccines and their method of use
CA2846486C (en) 2011-07-12 2019-08-20 Philadelphia Health & Education Corporation Novel clostridium difficile dna vaccine
BR112014001248B1 (en) 2011-07-21 2020-12-08 The General Hospital Corporation apparatus and method for affecting subcutaneous adipose tissue
CA2848410A1 (en) 2011-09-16 2013-03-21 The Trustees Of The University Of Pennsylvania Rna engineered t cells for the treatment of cancer
US9708384B2 (en) 2011-09-22 2017-07-18 The Trustees Of The University Of Pennsylvania Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
EA033242B1 (en) 2011-10-12 2019-09-30 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Improved nucleic acids and human papilloma virus proteins, vaccines and compositions based thereon and methods of inducing an immune response against hpv using the same
JP5898324B2 (en) 2011-10-24 2016-04-06 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Improved HCV vaccine and method of use thereof
WO2013063419A2 (en) 2011-10-28 2013-05-02 The Trustees Of The University Of Pennsylvania A fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
KR102445129B1 (en) 2011-12-12 2022-09-20 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Compositions, comprising improved il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
CA2858884A1 (en) 2011-12-12 2013-06-20 The Trustees Of The University Of Pennsylvania Proteins comprising mrsa pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat mrsa infections
EP4275699A3 (en) 2012-02-22 2024-01-03 The Trustees of the University of Pennsylvania Use of the cd2 signaling domain in second-generation chimeric antigen receptors
KR20140135715A (en) 2012-02-22 2014-11-26 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Use of icos-based cars to enhance antitumor activity and car persistence
MX363667B (en) 2012-04-10 2019-03-29 Univ Pennsylvania Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same.
US9597388B2 (en) 2012-04-12 2017-03-21 The Trustees Of The University Of Pennslyvania Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
BR112015000638A2 (en) 2012-07-13 2017-08-08 Univ Pennsylvania isolated nucleic acid sequence, cell, methods for stimulating a cell-mediated immune response to a target cell or tissue population in a mammal, for providing antitumor immunity in a mammal, for treating a mammal having a disease, disorder or condition associated with high expression of a tumor antigen
WO2014055442A2 (en) 2012-10-01 2014-04-10 The Trustees Of The University Of Pennsylvania Compositions and methods for targeting stromal cells for the treatment of cancer
US10117896B2 (en) 2012-10-05 2018-11-06 The Trustees Of The University Of Pennsylvania Use of a trans-signaling approach in chimeric antigen receptors
US9598489B2 (en) 2012-10-05 2017-03-21 The Trustees Of The Univeristy Of Pennsylvania Human alpha-folate receptor chimeric antigen receptor
US9020605B2 (en) * 2012-10-25 2015-04-28 Oncosec Medical Incorporated Electroporation device
US10220082B2 (en) 2012-12-13 2019-03-05 Inovio Pharmaceuticals, Inc. WT1 vaccine
WO2014130359A1 (en) 2013-02-20 2014-08-28 Cytrellis Biosystems, Inc. Methods and devices for skin tightening
EA034056B1 (en) 2013-03-12 2019-12-23 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Improved vaccines for human papilloma virus and methods for using the same
BR112015022367B1 (en) 2013-03-15 2021-06-22 The Trustees Of The University Of Pennsylvania VACCINE, NUCLEIC ACID MOLECULE, AND AMINO ACID MOLECULE
KR102276405B1 (en) 2013-03-15 2021-07-12 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
US11013917B2 (en) 2013-06-21 2021-05-25 Newsouth Innovations Pty Limited Method and apparatus for close-field electroporation
BR112016002695B1 (en) 2013-08-09 2022-09-20 Cytrellis Biosystems, Inc DEVICE WITH AN ABLATIVE DEVICE, A REMOVAL DEVICE AND A POSITIONING DEVICE
CN203451533U (en) * 2013-08-27 2014-02-26 苏州文曲生物微系统有限公司 Electroporation system based on novel microelectrode chip
CN105829341A (en) 2013-12-13 2016-08-03 宾夕法尼亚大学理事会 DNA antibody constructs and method of using same
US10953143B2 (en) 2013-12-19 2021-03-23 Cytrellis Biosystems, Inc. Methods and devices for manipulating subdermal fat
US11028143B2 (en) 2014-01-21 2021-06-08 Novartis Ag Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules
CN107106609A (en) 2014-10-31 2017-08-29 宾夕法尼亚大学董事会 Stimulate and extend the composition and method of T cell
CA2964948A1 (en) 2014-10-31 2016-05-06 The Trustees Of The University Of Pennsylvania Altering gene expression in modified t cells and uses thereof
JP2017533774A (en) 2014-11-14 2017-11-16 サイトレリス バイオシステムズ，インコーポレーテッド Device and method for skin ablation
WO2016089862A1 (en) 2014-12-01 2016-06-09 The Trustees Of The University Of Pennsylvania Dna antibody constructs and method of using same
EP3242947B1 (en) 2015-01-09 2020-05-27 OncoSec Medical Incorporated Gene therapy and electroporation for the treatment of malignancies
EP4223873A3 (en) 2015-01-31 2023-09-06 The Trustees of the University of Pennsylvania Compositions and methods for t cell delivery of therapeutic molecules
CA2981049A1 (en) 2015-03-26 2016-09-29 Oncosec Medical Incorporated Combination of an immunostimulatory cytokine and a checkpoint inhibitor for the treatment of malignancies
CA2981474A1 (en) * 2015-03-31 2016-10-06 Oncosec Medical Incorporated Systems and methods for improved tissue-sensing based electroporation
WO2016178996A1 (en) 2015-05-01 2016-11-10 The Regents Of The University Of California Glycan-dependent immunotherapeutic molecules
NZ737871A (en) 2015-06-25 2023-02-24 Newsouth Innovations Pty Ltd Electroporation system for controlled localized therapeutics delivery
EP3340998B1 (en) 2015-08-28 2023-01-11 The Trustees of the University of Pennsylvania Methods and compositions for cells expressing a chimeric intracellular signaling molecule
KR101788301B1 (en) * 2015-09-17 2017-10-20 주식회사 엘림텍 Electroporation device and control method thereof
JP7079729B2 (en) 2015-12-18 2022-06-02 オンコセック メディカル インコーポレイテッド Plasmid constructs for heterologous protein expression and how to use them
IL296877A (en) * 2015-12-22 2022-12-01 Inovio Pharmaceuticals Inc Electroporation device having a battery pack with power switch
AU2017214656B2 (en) 2016-02-05 2022-08-25 Inovio Pharmaceuticals, Inc. Cancer vaccines and methods of treatment using the same
EP3432924A1 (en) 2016-03-23 2019-01-30 Novartis AG Cell secreted minibodies and uses thereof
US11166743B2 (en) 2016-03-29 2021-11-09 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing
AU2017249424B2 (en) 2016-04-13 2023-08-24 Janssen Pharmaceuticals, Inc. Recombinant arterivirus replicon systems and uses thereof
JP2018035137A (en) 2016-07-13 2018-03-08 マブイミューン ダイアグノスティックス エイジーＭａｂｉｍｍｕｎｅ Ｄｉａｇｎｏｓｔｉｃｓ Ａｇ Novel anti-fibroblast activated protein (FAP) binding agent and use thereof
US11464954B2 (en) 2016-09-21 2022-10-11 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing
BR112019007433A2 (en) 2016-10-17 2019-07-02 Synthetic Genomics Inc recombinant virus replicon systems and uses thereof
US11845939B2 (en) 2016-12-05 2023-12-19 Janssen Pharmaceuticals, Inc. Compositions and methods for enhancing gene expression
GB201710973D0 (en) 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
SE541651C2 (en) 2017-07-28 2019-11-19 Scandinavian Chemotech Ab An electrode device and a needle electrode for use in delivery of electrical pulses to a desired tissue of a mammal
JP2021506255A (en) 2017-12-13 2021-02-22 イノビオ ファーマシューティカルズ，インコーポレイティド Cancer vaccines targeting PRAME and their use
MX2020006226A (en) 2017-12-13 2020-11-18 Inovio Pharmaceuticals Inc Cancer vaccines targeting mesothelin and uses thereof.
BR112020010542A2 (en) 2017-12-13 2020-12-01 Inovio Pharmaceuticals, Inc. nucleic acid molecules, vector, composition, proteins, uses of the above, and vaccines
WO2019123252A1 (en) 2017-12-19 2019-06-27 Janssen Sciences Ireland Unlimited Company Hepatitis b virus (hbv) vaccines and uses thereof
US11021692B2 (en) 2017-12-19 2021-06-01 Janssen Sciences Ireland Unlimited Company Hepatitis B virus (HBV) vaccines and uses thereof
SG11202005710YA (en) 2017-12-19 2020-07-29 Janssen Sciences Ireland Unlimited Co Methods and compositions for inducing an immune response against hepatitis b virus (hbv)
US11389531B2 (en) 2017-12-19 2022-07-19 Janssen Sciences Ireland Unlimited Company Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines
US11020476B2 (en) 2017-12-19 2021-06-01 Janssen Sciences Ireland Unlimited Company Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)
AU2018396083A1 (en) 2017-12-29 2020-05-21 Cellectis Method for improving production of CAR T cells
JP2021511318A (en) 2018-01-19 2021-05-06 ヤンセン ファーマシューティカルズ，インコーポレーテッド Induction and enhancement of immune response using recombinant replicon system
WO2020092455A2 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Car t cell transcriptional atlas
US11185692B2 (en) * 2018-10-31 2021-11-30 Emily Ireland Light touch therapeutic headset
US11071860B2 (en) 2019-02-06 2021-07-27 Oncosec Medical Incorporated Systems and methods for detecting fault conditions in electroporation therapy
US20220177863A1 (en) 2019-03-18 2022-06-09 The Broad Institute, Inc. Type vii crispr proteins and systems
CN113661180A (en) 2019-03-27 2021-11-16 宾夕法尼亚大学董事会 Tn-MUC1 Chimeric Antigen Receptor (CAR) T cell therapy
US11660139B2 (en) 2019-04-10 2023-05-30 Radioclash Inc. Electroporation probe
CN109999340A (en) * 2019-04-29 2019-07-12 杭州睿笛生物科技有限公司 A kind of loaded self-adaptive nanosecond pulse generation device
WO2020255016A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
WO2020255017A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
CA3140708A1 (en) 2019-06-18 2020-12-24 Helen Horton Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
WO2020254876A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Virus-like particle delivery of hepatitis b virus (hbv) vaccines
WO2020255015A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
WO2020255022A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and aminopyridine derivatives as hpk1 inhibitors
WO2020255008A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAi
WO2020255019A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and a quinazoline derivative
US20220241402A1 (en) 2019-06-18 2022-08-04 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and quinazoline derivatives
WO2020255010A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of recombinant interleukin 12 construct and hepatitis b virus (hbv) vaccines
WO2020255035A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and pyrimidine derivatives
WO2020255042A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and a pyrimidine derivative
CN114630675A (en) 2019-06-18 2022-06-14 爱尔兰詹森科学公司 Combination of Hepatitis B Virus (HBV) vaccine and anti-PD-1 or anti-PD-L1 antibody
CA3140748A1 (en) 2019-06-18 2020-12-24 Helen Horton Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being sulfonamide derivatives
WO2020255013A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being amide derivatives
WO2020255018A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Hepatitis b virus (hbv) vaccines and uses thereof
WO2020255021A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and small molecule pdl1 or pd1 inhibitor
JP2022536945A (en) 2019-06-18 2022-08-22 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー Combination of hepatitis B virus (HBV) vaccine and RNAi targeting HBV
US20220233684A1 (en) 2019-06-18 2022-07-28 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and pd-l1 inhibitors
MA56520A (en) 2019-06-18 2022-04-27 Janssen Sciences Ireland Unlimited Co CONSTRUCTION OF RECOMBINANT INTERLEUKIN-12 AND ITS USES
EP3986460A2 (en) 2019-06-18 2022-04-27 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and anti-pd-1 antibody
US20220305118A1 (en) 2019-06-20 2022-09-29 Janssen Sciences Ireland Unlimited Company Carbohydrate nanocarrier delivery of hepatitis b virus (hbv) vaccines
WO2020255062A1 (en) 2019-06-20 2020-12-24 Janssen Sciences Ireland Unlimited Company Lipid nanoparticle or liposome delivery of hepatitis b virus (hbv) vaccines
KR20220061977A (en) 2019-08-12 2022-05-13 퓨리노미아 바이오테크, 아이엔씨. Methods and compositions for promoting and enhancing T cell mediated immune response through ADCC targeting of CD39 expressing cells
TW202128775A (en) 2019-10-16 2021-08-01 英商阿法克塔生命科學有限公司 Pd-l1 inhibitor - tgfβ inhibitor bispecific drug moieties
CN115315446A (en) 2020-03-06 2022-11-08 Go医疗股份有限公司 anti-sugar-CD 44 antibodies and uses thereof
CA3172447A1 (en) 2020-03-27 2021-09-30 Erik Hans MANTING In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
CN115916963A (en) 2020-03-27 2023-04-04 门德斯有限公司 Ex vivo use of modified cells of leukemia origin for enhancing the efficacy of adoptive cell therapy
GB202101299D0 (en) 2020-06-09 2021-03-17 Avacta Life Sciences Ltd Diagnostic polypetides and methods
IL298874A (en) 2020-06-12 2023-02-01 Univ Rochester ENCODING AND EXPRESSION OF ACE-tRNAs
AU2021303478A1 (en) 2020-07-08 2023-02-16 Janssen Sciences Ireland Unlimited Company RNA replicon vaccines against HBV
EP4210832A1 (en) 2020-09-14 2023-07-19 Vor Biopharma, Inc. Chimeric antigen receptors for treatment of cancer
JP2023547520A (en) 2020-11-05 2023-11-10 メンドゥス・ベスローテン・フェンノートシャップ Use of tumor-independent antigens in immunotherapy
TW202245809A (en) 2020-12-18 2022-12-01 美商詹森藥物公司 Combination therapy for treating hepatitis b virus infection
EP4267740A1 (en) 2020-12-28 2023-11-01 Arcturus Therapeutics, Inc. Transcription activator-like effector nucleases (talens) targeting hbv
JP2024512324A (en) 2021-03-05 2024-03-19 ジーオー セラピューティクス，インコーポレイテッド Anti-glycoCD44 antibodies and their uses
KR20230157388A (en) 2021-03-12 2023-11-16 멘두스 비.브이. Methods of vaccination and uses of CD47 blockade
US20230001169A1 (en) * 2021-06-30 2023-01-05 Inovio Pharmaceuticals, Inc. Electrode Arrays For Electroporation, and Related Systems and Methods
WO2023010118A1 (en) 2021-07-29 2023-02-02 Vor Biopharma Inc. Nfat-responsive reporter systems for assessing chimeric antigen receptor activation and methods of making and using the same
WO2023010126A2 (en) 2021-07-29 2023-02-02 Vor Biopharma Inc. Chimeric antigen receptors for treatment of cancer
AU2022324456A1 (en) 2021-08-05 2024-02-15 Go Therapeutics, Inc. Anti-glyco-muc4 antibodies and their uses
WO2023034571A1 (en) 2021-09-03 2023-03-09 Go Therapeutics, Inc. Anti-glyco-lamp1 antibodies and their uses
CA3230934A1 (en) 2021-09-03 2023-03-09 Go Therapeutics, Inc. Anti-glyco-cmet antibodies and their uses
WO2023150753A1 (en) 2022-02-07 2023-08-10 University Of Rochester Optimized sequences for enhanced trna expression or/and nonsense mutation suppression
WO2023215874A1 (en) * 2022-05-05 2023-11-09 Renbio, Inc. Device related to therapeutic dna delivery
US20240002800A1 (en) 2022-05-16 2024-01-04 Mendus B.V. Use of leukemia-derived cells for enhancing natural killer (nk) cell therapy
WO2023233290A1 (en) 2022-05-31 2023-12-07 Janssen Sciences Ireland Unlimited Company Rnai agents targeting pd-l1

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674267A (en) * 1993-03-30 1997-10-07 Centre National De La Recherche Scientifique Electric pulse applicator using pairs of needle electrodes for the treatment of biological tissue
US5702359A (en) * 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US6241701B1 (en) * 1997-08-01 2001-06-05 Genetronics, Inc. Apparatus for electroporation mediated delivery of drugs and genes
EP1142606A2 (en) * 2000-04-06 2001-10-10 Varian Medical Systems, Inc. Multipurpose template and needles for the delivery and monitoring of multiple minimally invasive therapies
US20020010415A1 (en) * 2000-05-22 2002-01-24 Simon Adam J. System and method for assessing the performance of a pharmaceutical agent delivery system
EP1240917A1 (en) * 1993-04-01 2002-09-18 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
WO2003086534A1 (en) * 2002-04-05 2003-10-23 Ichor Medical Systems Inc. Method and apparatus for delivery of therapeutic agents

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US578611A (en) 1897-03-09 Thirds to louis f
US2223447A (en) 1936-07-23 1940-12-03 Rca Corp Short-wave radiotherapy system
US2239432A (en) 1939-07-12 1941-04-22 Gen Electric Excitation circuit for dynamoelectric machines
US2827851A (en) 1954-08-13 1958-03-25 Peter B Ferrara Energizer assembly
US2970545A (en) 1956-01-23 1961-02-07 Magnavox Co Energy converting device
US3060923A (en) 1959-01-07 1962-10-30 Teca Corp Coaxial electrode structure and a method of fabricating same
US3087486A (en) 1959-03-05 1963-04-30 Cenco Instr Corp Cardiac electrode means
US3162592A (en) 1960-04-20 1964-12-22 Pohl Herbert Ackland Materials separation using non-uniform electric fields
US3078850A (en) 1960-08-26 1963-02-26 Imp Electronics Inc Electrochemotherapeutic cardiac device
US3224436A (en) 1961-04-10 1965-12-21 Honeywell Regulator Co Hypodermic apparatus for measuring hydrogen ion concentration of blood within a living body
US3313293A (en) 1964-01-13 1967-04-11 Hewlett Packard Co Multi-electrode needle
US3568660A (en) 1967-11-20 1971-03-09 Battelle Development Corp Pacemaker catheter
US3682162A (en) 1968-12-13 1972-08-08 Wellcome Found Combined electrode and hypodermic syringe needle
US3834392A (en) 1973-02-01 1974-09-10 Kli Inc Laparoscopy system
US3900020A (en) 1974-05-02 1975-08-19 Chuck Lock Electronic acupuncture device
US4016886A (en) 1974-11-26 1977-04-12 The United States Of America As Represented By The United States Energy Research And Development Administration Method for localizing heating in tumor tissue
US4119102A (en) 1975-07-11 1978-10-10 Leveen Harry H Radio frequency treatment of tumors while inducing hypotension
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4155363A (en) 1976-08-23 1979-05-22 International Electrolysis Group Inc. Electronically controlled apparatus for electrolytic depilation
DE2800039C2 (en) 1978-01-02 1984-06-20 Horst Dr.Med. 6700 Ludwigshafen Kief Acupuncture device
US4237896A (en) 1979-08-01 1980-12-09 Senil Nominees Pty. Ltd Immobilizing animals
US4524770A (en) 1983-01-25 1985-06-25 Ahmad Orandi Endoscope injection needle
US4476004A (en) 1983-04-08 1984-10-09 D.E.P. Systems, Inc. Apparatus for electrofusion of biological particles
US4663292A (en) 1984-12-21 1987-05-05 Wong Daniel T High-voltage biological macromolecule transfer and cell fusion system
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US4969468A (en) 1986-06-17 1990-11-13 Alfred E. Mann Foundation For Scientific Research Electrode array for use in connection with a living body and method of manufacture
FR2607708B3 (en) 1986-12-05 1989-02-24 Bontemps Raymond DEVICE FOR SUBCUTANEOUS TRANSFER OF MEDICINAL SUBSTANCES
US4822470A (en) 1987-10-09 1989-04-18 Baylor College Of Medicine Method of and apparatus for cell poration and cell fusion using radiofrequency electrical pulses
US4970154A (en) 1987-10-09 1990-11-13 Baylor College Of Medicine Method for inserting foreign genes into cells using pulsed radiofrequency
EP0398960B1 (en) 1988-01-21 1995-12-06 Massachusetts Institute Of Technology Transport of molecules across tissue using electroporation
US5389069A (en) 1988-01-21 1995-02-14 Massachusetts Institute Of Technology Method and apparatus for in vivo electroporation of remote cells and tissue
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5137817A (en) 1990-10-05 1992-08-11 Amoco Corporation Apparatus and method for electroporation
US5545130A (en) 1992-04-08 1996-08-13 Genetronics, Inc. Flow through electroporation method
US5501662A (en) 1992-05-22 1996-03-26 Genetronics, Inc. Implantable electroporation method and apparatus for drug and gene delivery
US5507724A (en) 1992-07-01 1996-04-16 Genetronics, Inc. Electroporation and iontophoresis apparatus and method for insertion of drugs and genes into cells
US5273525A (en) 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
US5318514A (en) * 1992-08-17 1994-06-07 Btx, Inc. Applicator for the electroporation of drugs and genes into surface cells
US5464386A (en) 1992-08-17 1995-11-07 Genetronics, Inc. Transdermal drug delivery by electroincorporation of vesicles
US5462520A (en) 1992-08-17 1995-10-31 Genetronics, Inc. Transsurface drug delivery by electrofusion of microbubbles to the tissue surface
US5688233A (en) 1992-08-17 1997-11-18 Genetronics, Inc. Electronincorporation enhanced transdermal delivery of molecules
US5468223A (en) 1992-11-30 1995-11-21 C.N.R.S. Paris Electrochemotherapy
US5993434A (en) 1993-04-01 1999-11-30 Genetronics, Inc. Method of treatment using electroporation mediated delivery of drugs and genes
JP3119486B2 (en) 1994-06-17 2000-12-18 久光製薬株式会社 Electrode for iontophoresis and device using the same
US5518264A (en) 1995-03-14 1996-05-21 Broughton; Timothy C. Free heel/anterior release ski binding
US5810762A (en) 1995-04-10 1998-09-22 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5628728A (en) 1995-05-31 1997-05-13 Ekos Corporation Medicine applying tool
US5859327A (en) 1995-08-22 1999-01-12 Genetronics, Inc. Electroporation-mediated molecular transfer in intact plants
US5944710A (en) 1996-06-24 1999-08-31 Genetronics, Inc. Electroporation-mediated intravascular delivery
US5869326A (en) 1996-09-09 1999-02-09 Genetronics, Inc. Electroporation employing user-configured pulsing scheme
US5704908A (en) 1996-10-10 1998-01-06 Genetronics, Inc. Electroporation and iontophoresis catheter with porous balloon
JP3366548B2 (en) 1997-02-26 2003-01-14 久光製薬株式会社 Device structure for iontophoresis and method of manufacturing the same
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
KR100427786B1 (en) 1997-04-03 2004-04-30 일렉트로우펙트 에이에스 Method and device for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
US5873849A (en) 1997-04-24 1999-02-23 Ichor Medical Systems, Inc. Electrodes and electrode arrays for generating electroporation inducing electrical fields
US6216034B1 (en) 1997-08-01 2001-04-10 Genetronics, Inc. Method of programming an array of needle electrodes for electroporation therapy of tissue
US6055453A (en) 1997-08-01 2000-04-25 Genetronics, Inc. Apparatus for addressing needle array electrodes for electroporation therapy
TW368420B (en) 1997-11-04 1999-09-01 Genetronics Inc Apparatus and method for transdermal molecular delivery by applying sufficient amplitude of electric field to induce migration of molecules through pores in the stratum corneum
US6208893B1 (en) 1998-01-27 2001-03-27 Genetronics, Inc. Electroporation apparatus with connective electrode template
US6120493A (en) 1998-01-27 2000-09-19 Genetronics, Inc. Method for the introduction of therapeutic agents utilizing an electroporation apparatus
CA2330211A1 (en) 1998-06-08 1999-12-16 Karel Petrak Formulations for electroporation
US6302874B1 (en) 1998-07-13 2001-10-16 Genetronics, Inc. Method and apparatus for electrically assisted topical delivery of agents for cosmetic applications
US6192270B1 (en) 1998-08-14 2001-02-20 Genetronics, Inc. Apparatus and method for the delivery of drugs and genes into tissue
US6150148A (en) 1998-10-21 2000-11-21 Genetronics, Inc. Electroporation apparatus for control of temperature during the process
US6314316B1 (en) 1998-12-17 2001-11-06 University Of South Florida Nonpenetrating electroporation device and method
EP1148885A4 (en) 1999-02-08 2002-05-08 Chiron Corp Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
US6387671B1 (en) * 1999-07-21 2002-05-14 The Regents Of The University Of California Electrical impedance tomography to control electroporation
US6300108B1 (en) 1999-07-21 2001-10-09 The Regents Of The University Of California Controlled electroporation and mass transfer across cell membranes
US7245963B2 (en) * 2002-03-07 2007-07-17 Advisys, Inc. Electrode assembly for constant-current electroporation and use

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674267A (en) * 1993-03-30 1997-10-07 Centre National De La Recherche Scientifique Electric pulse applicator using pairs of needle electrodes for the treatment of biological tissue
EP1240917A1 (en) * 1993-04-01 2002-09-18 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5702359A (en) * 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US6241701B1 (en) * 1997-08-01 2001-06-05 Genetronics, Inc. Apparatus for electroporation mediated delivery of drugs and genes
EP1142606A2 (en) * 2000-04-06 2001-10-10 Varian Medical Systems, Inc. Multipurpose template and needles for the delivery and monitoring of multiple minimally invasive therapies
US20020010415A1 (en) * 2000-05-22 2002-01-24 Simon Adam J. System and method for assessing the performance of a pharmaceutical agent delivery system
WO2003086534A1 (en) * 2002-04-05 2003-10-23 Ichor Medical Systems Inc. Method and apparatus for delivery of therapeutic agents

Also Published As

Publication number Publication date
US8209006B2 (en) 2012-06-26
HUE038018T2 (en) 2018-09-28
CA2578847A1 (en) 2005-03-24
WO2005025669A2 (en) 2005-03-24
US20050052630A1 (en) 2005-03-10
PL1673140T3 (en) 2018-08-31
TWI246930B (en) 2006-01-11
ES2668384T3 (en) 2018-05-17
CA2578847C (en) 2014-01-28
AR045603A1 (en) 2005-11-02
EP1673140B1 (en) 2018-03-21
TW200510028A (en) 2005-03-16
EP1673140A2 (en) 2006-06-28

Similar Documents

Publication Publication Date Title
WO2005025669A3 (en) Constant current electroporation device and methods of use
WO2008048632A8 (en) Electroporation devices and methods of using same for electroporation of cells in mammals
Armstrong-James et al. Carbon fibre microelectrodes
CA1215128A (en) Electric nerve stimulator device
US5318514A (en) Applicator for the electroporation of drugs and genes into surface cells
ATE387150T1 (en) APPARATUS AND METHOD FOR PERFORMING AN ELECTROSURGICAL PROCESS
DE602004004675D1 (en) SELECTION OF NEUROSTIMULATOR PARAMETER CONFIGURATIONS WITH NEURAL NETWORKS
FR2528709A1 (en) BIOLOGICAL ELECTRIC STIMULATOR
CA2266347A1 (en) Electroporation and iontophoresis catheter with porous balloon
ATE499143T1 (en) CONTEXT-SENSITIVE COLLECTION OF NEUROSTIMULATION THERAPY DATA
DE60203641D1 (en) METHOD AND DEVICE FOR THE ELECTRICAL STIMULATION OF TISSUE
DE60121194D1 (en) SYSTEM FOR CHANGING THERAPY PARAMETERS
US20050192645A1 (en) Method to produce a balanced dorsiflexion during the gait of patients with foot drop
CN103584851A (en) Multichannel neuron signal collection controlling and transmission device
KR20170129685A (en) Automated measurement and control system for tattoo formation
WO2007059162A3 (en) Unipolar electric pulse generator
CN104173044A (en) Closed-loop system used for epilepsy treatment
US7904172B2 (en) Programmable apparatus and method for optimizing and real time monitoring of gene transfection based on user configured arbitrary waveform pulsing train
Swett et al. Electrical stimulation of peripheral nerve
CN100453132C (en) Trauma ulcer therapeutic equipment capable of promoting hyaluronic acid transdermal absorption
CN103246348A (en) Quantitative analysis system and method for electric touches
CN104984476A (en) Microelectrode array digital acupuncture treatment method and device
CN201346203Y (en) Digital and photoelectrical acupoint detecting and treating pen
US8954169B2 (en) Systems and methods for loading a pre-curved electrode array onto a straightening member
CN205339063U (en) Nucleus pulposus forceps

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MK MN MW MX MZ NA NI NO NZ PG PH PL PT RO RU SC SD SE SG SK SY TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SZ TZ UG ZM ZW AM AZ BY KG MD RU TJ TM AT BE BG CH CY DE DK EE ES FI FR GB GR HU IE IT MC NL PL PT RO SE SI SK TR BF CF CG CI CM GA GN GQ GW ML MR SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004788598

Country of ref document: EP

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWP Wipo information: published in national office

Ref document number: 2004788598

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2578847

Country of ref document: CA